INTERLEUKIN GENETICS INC - FORM 10-Q - EX-32.1 - CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 - August 12, 2011

Attached files

file filename
EXCEL - IDEA: XBRL DOCUMENT - INTERLEUKIN GENETICS INCFinancial_Report.xls
10-Q - QUARTERLY REPORT - INTERLEUKIN GENETICS INCv231120_10q.htm
EX-10.1 - CONTRACT SERVICES AGREEMENT - INTERLEUKIN GENETICS INCv231120_ex10-1.htm
EX-31.2 - CERTIFICATION BY PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - INTERLEUKIN GENETICS INCv231120_ex31-2.htm
EX-31.1 - CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 - INTERLEUKIN GENETICS INCv231120_ex31-1.htm
EXHIBIT 32.1
 
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
(SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18,
UNITED STATES CODE)
 
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18 United States Code), each of the undersigned officers of Interleukin Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
 
The Quarterly Report on Form 10-Q for the quarter ended June 30, 2011 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: August 12, 2011
/s/ Lewis H. Bender
 
Lewis H. Bender
Chief Executive Officer
   
Date: August 12, 2011
/s/ Eliot M. Lurier
 
Eliot M. Lurier
Chief Financial Officer

 
 
 

INTERLEUKIN GENETICS INC Reports

Also read